Skip to main content

Want a detailed portfolio tracker?

Akebia Therapeutics (AKBA) Total Assets (2011 - 2026)

Akebia Therapeutics (AKBA) total assets from Dec 31, 2011 to Mar 31, 2026. The current Akebia Therapeutics (AKBA) total assets is $363M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Assets

Total Assets

Akebia Therapeutics (AKBA) Total Assets CAGR table

PeriodCAGR
1 Year TTM+51.20%
3 Years TTM-3.22%
5 Years TTM-11.67%
10 Years TTM+7.86%

Annual Total Assets change of Akebia Therapeutics (AKBA)

YearTotal AssetsChange
2025$377M
+70.65%
2024$221M
-8.70%
2023$242M
-32.12%
2022$356M
N/A
2022$356M
-19.85%
2022$444M
-16.16%
2022$530M
-2.20%
2022$542M
+3.09%
2021$526M
-0.72%
2021$529M
-17.82%
2020$644M
N/A
2020$0
-100.00%
2019$771M
N/A
2019$0
-100.00%
2018$997M
+173.59%
2017$364M
+21.33%
2016$300M
+110.03%
2015$143M
+28.77%
2014$111M
+220.16%
2013$35M
N/A
2012$0
N/A
2011$0
N/A

Comparison Akebia Therapeutics (AKBA) total assets with competitors

Akebia Therapeutics (AKBA) total assets is $362.52M.

TickerNameTotal AssetsUpside
RDYDr. Reddy`s Laboratories Ltd$567.88B+156546.95%
UPCUniverse Pharmaceuticals Inc$69.30B+19017.14%
TEVATeva- Pharmaceutical Industries Ltd$40.04B+10944.91%
VTRSViatris Inc$36.83B+10060.71%
HLNHaleon plc$32.57B+8885.06%
BHCBausch Health Companies Inc$24.50B+6657.70%
ZTSZoetis Inc - Class A$15.15B+4080.18%
ELANElanco Animal Health Inc$13.22B+3547.25%
PRGOPerrigo Company plc$7.98B+2102.17%
UTHRUnited Therapeutics Corp$6.71B+1752.09%
NBIXNeurocrine Biosciences Inc$4.91B+1253.36%
ALKSAlkermes plc$4.26B+1074.58%
AMRXAmneal Pharmaceuticals Inc - Class A$3.54B+876.56%
PBHPrestige Consumer Healthcare Inc$3.49B+863.90%
LNTHLantheus Holdings Inc$2.35B+547.30%
HIMSHims & Hers Health Inc - Class A$2.27B+525.36%
TLRYTilray Brands Inc$2.07B+472.31%
HCMHUTCHMED (China) Ltd$1.78B+389.89%
COLLCollegium Pharmaceutical Inc$1.65B+355.69%
AMPHAmphastar Pharmaceuticals Inc$1.65B+354.64%
EVOEvotec SE$1.64B+352.81%
SUPNSupernus Pharmaceuticals Inc$1.50B+313.97%
PAHCPhibro Animal Health Corp - Class A$1.45B+298.63%
ANIPANI Pharmaceuticals Inc$1.42B+292.25%
ALVOAlvotech$1.42B+292.02%
EBSEmergent Biosolutions Inc$1.32B+264.23%
PCRXPacira BioSciences Inc$1.21B+233.37%
INDVIndivior Plc$1.20B+230.19%
CRONCronos Group Inc$1.17B+223.32%
CGCCanopy Growth Corporation$1.11B+205.14%
DVAXDynavax Technologies Corp$946.51M+161.09%
KNSAKiniksa Pharmaceuticals International plc. - Class A$825.28M+127.65%
ACBAurora Cannabis Inc$775.29M+113.86%
INCRINC Research Holdings Inc$690.55M+90.49%
OGIOrganiGram Holdings Inc$522.66M+44.17%
ORGOOrganogenesis Holdings Inc - Class A$519.99M+43.44%
BCRXBiocryst Pharmaceuticals Inc$465.05M+28.28%
ESPREsperion Therapeutics Inc$462.53M+27.59%
ZYBTZhengye Biotechnology Holding Ltd$436.47M+20.40%
IRWDIronwood Pharmaceuticals Inc - Class A$434.57M+19.87%
DCPHDeciphera Pharmaceuticals Inc$420.93M+16.11%
HROWHarrow Inc$419.54M+15.73%
LQDALiquidia Corp$401.53M+10.76%
BIOABioAge Labs Inc$397.65M+9.69%
XERSXeris Biopharma Holdings Inc$392.01M+8.14%
KMDAKamada Ltd$383.02M+5.66%
AMLXAmylyx Pharmaceuticals Inc$293.60M-19.01%
LFCRLifecore Biomedical Inc$225.50M-37.80%
EOLSEvolus Inc$220.65M-39.14%
SIGASIGA Technologies Inc$219.39M-39.48%
ASRTAssertio Holdings Inc$211.30M-41.71%
AVDLAvadel Pharmaceuticals plc$199.45M-44.98%
ANIKAnika Therapeutics Inc$179.39M-50.52%
AQSTAquestive Therapeutics Inc$141.13M-61.07%
AYTUAytu BioPharma Inc$111.69M-69.19%
CTORCitius Oncology Inc$100.70M-72.22%
TKNOAlpha Teknova Inc$98.66M-72.79%
ETONEton Pharmaceuticals Inc$97.71M-73.05%
DERMJourney Medical Corp$91.53M-74.75%
IXHLIncannex Healthcare Ltd$80.28M-77.85%
SCYXScynexis Inc$77.63M-78.59%
CPIXCumberland Pharmaceuticals Inc$71.00M-80.42%
RMTIRockwell Medical Inc$57.42M-84.16%
BGMQilian International Holding Group Ltd - Class A$53.00M-85.38%
CPHIChina Pharma Holdings Inc$45.14M-87.55%
TXMDTherapeuticsMD Inc$37.58M-89.63%
BTAIBioXcel Therapeutics Inc$34.02M-90.61%
CRDLCardiol Therapeutics Inc - Class A$31.49M-91.31%
TLPHTalphera Inc$30.16M-91.68%
SBFMSunshine Biopharma Inc$27.93M-92.30%
BFRIBiofrontera Inc$24.79M-93.16%
IMCCIM Cannabis Corp$23.68M-93.47%
SXTCChina SXT Pharmaceuticals Inc$21.66M-94.02%
GELSGelteq Ltd$21.48M-94.08%
EVOKEvoke Pharma Inc$15.65M-95.68%
SNOASonoma Pharmaceuticals Inc$13.62M-96.24%
DRRXDurect Corp$12.48M-96.56%
YCBDcbdMD Inc$12.25M-96.62%
PRFXPRF Technologies Ltd$12.00M-96.69%
SHPHShuttle Pharmaceuticals Holdings Inc$11.81M-96.74%
APUSApimeds Pharmaceuticals US Inc$9.25M-97.45%
INMInMed Pharmaceuticals Inc$9.13M-97.48%
RGCRegencell Bioscience Holdings Ltd$5.76M-98.41%
CABRCaring Brands Inc$2.17M-99.40%